Patrick Soon-Shiong

Chairman & CEO, Nantworks

Dr. Soon-Shiong serves as Chairman of the Chan Soon-Shiong Family Foundation; Chairman and CEO of the Chan Soon-Shiong Institute for Advanced Health (the CSS Institute); the Healthcare Transformation Institute; National LambdaRail; and NantWorks,LLC. Dr. Soon-Shiong performed the world’s first encapsulated human islet transplant and the first pig to man islet cell transplant in diabetic patients. He invented and developed Abraxane, the nation’s first FDA approved protein nanoparticle albumin-bound delivery technology for the treatment of cancer, doubling the response rate in patients. A physician, surgeon and scientist, he has pioneered treatments for both diabetes and cancer, published over 100 scientific papers, and holds 50 US patents on groundbreaking advancements across myriad fields.

Soon-Shoing was previously a member of the 21st Century Council.